CVAR - ETF AI Analysis
Top Page
Cultivar ETF (CVAR)
Rating:57Neutral
Price Target:―
Positive Factors
Broad Sector Diversification
The ETF spreads its investments across many different sectors, which can help reduce the impact if any one industry struggles.
Multiple Strong Top Holdings
Several of the largest positions, such as Albemarle, Proto Labs, Newmont Mining, and Northwest Gas, have shown strong year-to-date performance that supports the fund’s overall results.
Positive Year-to-Date Performance
The fund has delivered a modest gain so far this year, showing it has held up reasonably well despite some recent short-term weakness.
Negative Factors
High Expense Ratio
The fund’s expense ratio is relatively high for an ETF, which means more of the returns are eaten up by fees over time.
Heavy U.S. Concentration
With the vast majority of its holdings in U.S. companies, the ETF offers limited geographic diversification and is heavily tied to the U.S. market.
Mixed Performance Among Top Holdings
Some key positions, including MarketAxess, Alexandria Equities, and Southwest Airlines, have shown weak year-to-date performance, which can drag on the fund’s returns.
CVAR vs. SPDR S&P 500 ETF (SPY)
AUM38.98M
RegionNorth America
Expense Ratio0.87%
Beta0.58
IssuerCultivar
Inception DateDec 21, 2021
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,362
30 Day Avg. Volume1,741
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
32.81Price Target Upside― Downside
Rating ConsensusHold
Number of Analyst Covering87
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CVAR Summary
The Cultivar ETF (CVAR) is an actively managed fund that looks across the total U.S. stock market for companies that appear cheap compared with their business strength, following a value-investing theme rather than a specific index. It holds a mix of large, mid, and small companies in many sectors, including health care, consumer goods, and technology. Well-known names in the fund include The Hershey Company and Southwest Airlines. Someone might invest in CVAR to seek long-term growth while diversifying across many industries, but its value-focused stocks can go up and down with the market and may lag popular growth stocks for long periods.
How much will it cost me?The Cultivar ETF (CVAR) has an expense ratio of 0.87%, which means you’ll pay $8.70 per year for every $1,000 invested. This expense ratio is higher than average because the fund is actively managed, focusing on identifying undervalued companies with strong fundamentals rather than simply tracking an index.
What would affect this ETF?The Cultivar ETF (CVAR) could benefit from a recovery in the U.S. economy, as value investing strategies often perform well during periods of market stability and growth. Positive trends in sectors like Health Care and Technology, which make up significant portions of the ETF, could also drive returns. However, rising interest rates or economic uncertainty might negatively impact some of its top holdings, such as real estate and energy companies, and broader market volatility could challenge its value-focused approach.
CVAR Top 10 Holdings
CVAR’s story is about a U.S.-focused value hunt that leans into health care and defensive names while sprinkling in industrials and materials. Proto Labs has been one of the fund’s bright spots, rising on solid growth and upbeat sentiment, while Humana and Albemarle are also adding some spark despite their own bumps. On the flip side, MarketAxess and Core Laboratories have been lagging, acting like a bit of an anchor. With no single mega-cap dominating, performance is driven by a mix of mid-sized, sector-diverse value plays rather than one star name.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Marketaxess Holdings | 3.18% | $1.23M | $4.29B | -47.38% | 68 Neutral | |
| Core Laboratories | 2.65% | $1.03M | $629.68M | 15.65% | 72 Outperform | |
| Healthcare Services | 2.41% | $935.63K | $1.40B | 41.07% | 72 Outperform | |
| Alexandria Equities | 2.22% | $859.20K | $9.26B | -27.29% | 47 Neutral | |
| Proto Labs | 2.19% | $847.85K | $1.78B | 89.46% | 70 Outperform | |
| Southwest Airlines | 1.87% | $726.62K | $20.19B | 24.07% | 66 Neutral | |
| Humana | 1.74% | $674.95K | $42.00B | 51.75% | 69 Neutral | |
| Northwest Gas | 1.65% | $637.98K | $2.06B | 25.39% | 73 Outperform | |
| The Hershey Company | 1.61% | $626.10K | $37.06B | 14.11% | 76 Outperform | |
| Eversource Energy | 1.60% | $621.70K | $26.28B | 7.80% | 66 Neutral |
CVAR Technical Analysis
Negative
―
Price Trends
28.64
Negative
29.01
Negative
28.39
Positive
Market Momentum
0.01
Negative
45.49
Neutral
21.86
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CVAR, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 28.60, equal to the 50-day MA of 28.64, and equal to the 200-day MA of 28.39, indicating a neutral trend. The MACD of 0.01 indicates Negative momentum. The RSI at 45.49 is Neutral, neither overbought nor oversold. The STOCH value of 21.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CVAR.
CVAR Peer Comparison
Comparison Results
Performance Comparison
CVAR
Cultivar ETF
28.51
2.63
10.16%
GMOV
GMO US Value ETF
―
―
―
SASS
M.D. Sass Concentrated Value ETF
―
―
―
VUSV
Vanguard Wellington U.S. Value Active ETF
―
―
―
GVLE
Goldman Sachs Value Opportunities ETF
―
―
―
USFE
First Eagle US Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents